📇 Rhumatologue · Salarié
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Praticien-chercheur
11 articles scientifiques publiés — formation continue solide
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Lupus · 2008
Mycophenolate mofetil (MMF) with prednisolone has been associated with high remission rates when used as induction treatment for lupus nephritis. This prospective, multicentre, cohort study investigates the efficacy and safety of this regimen over 24 weeks in 213 Chinese patients with active lupus nephritis (Classes III, IV, V or combination). Baseline activity index (AI) was 6.91 ± 3.33 and chronicity index (CI) was 1.9 ± 1.2. The remission rate was 82.6% at 24 weeks (complete remission, 34.3%; partial remission, 48.4%). There were significant ( P < 0.01) improvements in kidney function shown by reductions in proteinuria, serum albumin, serum creatinine and creatinine clearance, as well as in systemic lupus erythematosus disease activity index (SLEDAI) scores. Independent risk factors influencing remission were pathological classification (including Class V and III or Class V and IV nephritis) and elevated serum creatinine at baseline (OR 2.967, 95% CI: 1.479–6.332, P = 0.001 and OR 1.007, 95% CI: 1.002–1.011, P = 0.001, respectively). Patients with concomitant membranous features on biopsy had a lower remission rate than those with Class III and IV nephritis (66.7% vs 87.3%, P = 0.002). Renal biopsy was repeated in 25 patients following treatment. There was a transition to less severe pathological morphologies in majority of subjects. Infections were monitored throughout treatment: eight patients (3.8%) experienced bacterial infections, whereas herpes zoster occurred in seven patients. Nine patients (4.2%) suffered from gastrointestinal upset, which resolved without discontinuation of MMF. One patient became leucopenic, whereas another died from active disease unrelated to kidney symptoms. MMF combined with prednisolone is an effective and well-tolerated induction treatment for patients with active lupus nephritis and for controlling SLE systemic activity.
BMC complementary and alternative medicine · 2017
The open rheumatology journal · 2015
Osteoarthritis is a joint disease involved in articular cartilage, subchondral bone, meniscus and synovial membrane. This study sought to examine cartilage degeneration, subchondral bone mineral density (BMD) and meniscal mineral density (MD) in male Hartley, female Hartley and female strain 13 guinea pigs to determine the association of cartilage degeneration with subchondral BMD and meniscal MD. Cartilage degeneration, subchondral BMD and meniscal MD in 12 months old guinea pigs were examined with histochemistry, X-ray densitometry and calcium analysis. We found that male Hartley guinea pigs had more severe cartilage degeneration, subchondral BMD and meniscal MD than female Hartley guinea pigs, but not female strain 13 guinea pigs. Female strain 13 guinea pigs had more severe cartilage degeneration and higher subchondral BMD, but not meniscal MD, than female Hartley guinea pigs. These findings indicate that higher subchondral BMD, not meniscal MD, is associated with more severe cartilage degeneration in the guinea pigs and suggest that abnormal subchondral BMD may be a therapeutic target for OA treatment. These findings also indicate that the pathogenesis of OA in the male guinea pigs and female guinea pigs are different. Female strain 13 guinea pig may be used to study female gender-specific pathogenesis of OA.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Veterinary and comparative orthopaedics and traumatology : V.C.O.T · 2025 · Journal Article
H SM, McOnie RC, Bellefeuille SD, Tinga S, et al.
BMC complementary and alternative medicine · 2017 · Journal Article
Florence NT, Huguette ST, Hubert DJ, Raceline GK, et al.
The open rheumatology journal · 2015 · Journal Article
Sun Y, Scannell BP, Honeycutt PR, Mauerhan DR, et al.
The open orthopaedics journal · 2015 · Journal Article
H N, A P S, S B, A U, et al.
World journal of nuclear medicine · 2014 · Journal Article
Huguette YY, Kwame KA, Kojo WI, Francis H, et al.
The open orthopaedics journal · 2012 · Journal Article
M M, H G, S H, A J, et al.
Clinical rheumatology · 2025 · Journal Article
A K, M EA, M H, H A, et al.
Lupus · 2008 · Clinical Trial
F L, Y T, X P, L W, et al.
The Journal of the Association of Physicians of India · 2022 · Journal Article
Jagdish GA, Va L, H KS
Archives of osteoporosis · 2025 · Journal Article
N BV, A MS, A DR, H SG, et al.
Archives of gerontology and geriatrics · 2021 · Journal Article
M R, M A, H B, M O
✨ Profil synthétique
IA · 21/05/2026MME Huguette CAUGANT-HOUSSARD est une rhumatologue salariée avec des publications sur PubMed portant sur diverses pathologies. Ses travaux de recherche couvrent notamment l'arthrite juvénile, la corticothérapie, le lupus et l'ostéoporose. Elle a également contribué à des revues générales dans le domaine de la rhumatologie.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.